Index by Author

January/February 2014; Volume 68,Issue 1

  1. Blumel, J.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  2. Blumel, Johannes

    1. Viral Safety Perspective from the Paul-Ehrlich-Institut in Europe
      Johannes Blümel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 11-12; DOI: https://doi.org/10.5731/pdajpst.2014.00960

  3. Brorson, K.

    1. Conference Summary: Gaps, Lessons Learned, and Areas for Improvement
      K. Brorson, G. Miesegaes, O. Tounekti, J. Skene and J. Blumel
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 83-89; DOI: https://doi.org/10.5731/pdajpst.2014.00968

  4. Brorson, Kurt

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959
    2. Proceedings of the 2011 Viral Clearance Symposium (South San Francisco, CA)
      Kurt Brorson and Rich Levy
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 1; DOI: https://doi.org/10.5731/pdajpst.2014.00957
    3. Overview of 2009 Indianapolis Conference White Paper: The Goal of an Integrated Viral Clearance Strategy
      Kurt Brorson
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 2-5; DOI: https://doi.org/10.5731/pdajpst.2014.00958

  5. Chen, Dayue

    1. Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Virus-Retentive Filtration
      Dayue Chen
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 38-50; DOI: https://doi.org/10.5731/pdajpst.2014.00965

  6. Chen, Qi

    1. Viral Clearance Using Traditional, Well-Understood Unit Operations (Session I): Low-pH Inactivation
      Qi Chen
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 17-22; DOI: https://doi.org/10.5731/pdajpst.2014.00962

  7. Connell-crowley, Lisa

    1. Protocol for Evaluation of Virus Inactivation Using Low-pH Treatment
      Dominick Vacante and Lisa Connell-Crowley
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 90-97; DOI: https://doi.org/10.5731/pdajpst.2014.00969

  8. Fuchs, Chana

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959

  9. Hubbard, Brian

    1. Viral Clearance by Traditional Operations with Significant Knowledge Gaps (Session II): Protein A Chromatography
      Brian Hubbard
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 13-16; DOI: https://doi.org/10.5731/pdajpst.2014.00961
    2. Emerging Unit Operations (Session III): Hydroxyapatite, Mixed-Mode, and Adsorptive Membrane Chromatography; UV-C Inactivation; Chemical Precipitation
      Brian Hubbard and David Roush
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 51-65; DOI: https://doi.org/10.5731/pdajpst.2014.00966

  10. Hyams, Kenneth C.

    1. Role of Risk Assessments in Viral Safety: An FDA Perspective
      Lixin Xu, Sang Bong Lee, Chana Fuchs, Kenneth C. Hyams, Kurt Brorson and Patrick Swann
      PDA Journal of Pharmaceutical Science and Technology January 2014, 68 (1) 6-10; DOI: https://doi.org/10.5731/pdajpst.2014.00959
« Previous (Pages : 1 2 3 ... 3) Next »
Back to top

In This Issue